R
75
-2
ABT
60
-2
PPL
52
-2
MAC
65
-9
OMC
66
-2
SLG
66
-7
TGNA
59
-5
HPE
68
-4
XOM
48
-2
OKE
81
-2
PLD
48
-2
LMT
40
-2
LH
50
-2
JNJ
38
-3
ROP
65
2
FITB
66
-2
GS
79
-4
AEE
63
-3
MOS
38
-12
HES
63
-2
R
75
-2
ABT
60
-2
PPL
52
-2
MAC
65
-9
OMC
66
-2
SLG
66
-7
TGNA
59
-5
HPE
68
-4
XOM
48
-2
OKE
81
-2
PLD
48
-2
LMT
40
-2
LH
50
-2
JNJ
38
-3
ROP
65
2
FITB
66
-2
GS
79
-4
AEE
63
-3
MOS
38
-12
HES
63
-2
Financhill
Back

Ocular Therapeutix Quote, Financials, Valuation and Earnings

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
72

OCUL
Ocular Therapeutix

Last Price:
10.60
Seasonality Move:
21.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.

Ocular Therapeutix Price Quote

$10.60

Ocular Therapeutix Key Stats

Buy
72
Ocular Therapeutix (OCUL) is a Buy
Day range:
$10.46 - $11.05
52-week range:
$2.05 - $11.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
20.53
P/B ratio:
4.38%
Volume:
619.6K
Avg. volume:
1.2M
1-year change:
403.56%
Market cap:
$1.7B
Revenue:
$58.4M
EPS:
$-1.35

How Much Does Ocular Therapeutix Make?

Is Ocular Therapeutix Growing As A Company?

  • What Is Ocular Therapeutix's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.08%
  • What Is Ocular Therapeutix's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Ocular Therapeutix Stock Price Performance

What Is Ocular Therapeutix 52-Week High & Low?

Ocular Therapeutix Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ocular Therapeutix?

  • How Much Debt Does Ocular Therapeutix Have?
    Total long term debt quarterly is $67.1M
  • How Much Cash Does Ocular Therapeutix Have?
    Cash and short term investments quarterly total is $459.7M
  • What Is Ocular Therapeutix’s Book Value Per Share?
    Book value per share is 2.43

Is Ocular Therapeutix Cash Flow Positive?

  • What Is OCUL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$88.9M
  • What Is Ocular Therapeutix’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $483.5M
  • What Is Ocular Therapeutix’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.7M

Ocular Therapeutix Return On Invested Capital

  • Is Management Doing A Good Job?
    OCUL return on invested capital is -56.45%
  • What Is Ocular Therapeutix Return On Assets?
    ROA measures how assets are converting to revenues and is -43.43%
  • What Is OCUL Return On Equity?
    ROE is a measure of profitability and is -77.93%

Ocular Therapeutix Earnings Date & Stock Price

Ocular Therapeutix Competitors

  • Who Are Ocular Therapeutix's Competitors?
    Below is a list of companies who compete with Ocular Therapeutix or are related in some way:
    • 4D Molecular Therapeutics Inc (FDMT)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Ocular Therapeutix Dividend Yield

Ocular Therapeutix Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -21.88%
Revenue: 8.26% 3.75%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 16.56
Upside from Last Price: 56.18%

Major Shareholders

  • How many OCUL shares are owned by institutional investors?
    184.2M OCUL shares are owned by institutional investors
  • How many OCUL shares are owned by insiders?
    4.9M OCUL shares are owned by insiders